Chemotherapy in hormone-refractory prostate cancer

被引：1
作者：
Biedermann, B [1 ]
Pless, M [1 ]
Herrmann, R [1 ]
机构：
[1] Kantonsspital, Dept Innere Med, Abt Onkol, CH-4031 Basel, Switzerland
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 1999年 / 124卷 / 28-29期
关键词：
D O I：
10.1055/s-2007-1024434
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：874 / 879
页数：6
相关论文
共 57 条
[41]   KETOCONAZOLE EFFECTIVELY REVERSES MULTIDRUG-RESISTANCE IN HIGHLY RESISTANT KB CELLS [J].
SIEGSMUND, MJ ;
CARDARELLI, C ;
AKSENTIJEVICH, I ;
SUGIMOTO, Y ;
PASTAN, I ;
GOTTESMAN, MM .
JOURNAL OF UROLOGY, 1994, 151 (02) :485-491
[42]  
SLACK NH, 1984, UROL CLIN N AM, V11, P337
[43]   Doxorubicin and dose-escalated cyclophosphamide with granulocyte colony-stimulating factor for the treatment of hormone-resistant prostate cancer [J].
Small, EJ ;
Srinivas, S ;
Egan, B ;
McMillan, A ;
Rearden, TP .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (05) :1617-1625
[44]  
SMALL EJ, 1998, P AN M AM SOC CLIN, V17, pA308
[45]   Change in serum prostate-specific antigen as a marker of response to cytotoxic therapy for hormone-refractory prostate cancer [J].
Smith, DC ;
Dunn, RL ;
Strawderman, MS ;
Pienta, KJ .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (05) :1835-1843
[46]  
Tang DG, 1997, PROSTATE, V32, P284
[47]   TREATMENT OF METASTATIC PROSTATIC-CANCER WITH LOW-DOSE PREDNISONE - EVALUATION OF PAIN AND QUALITY OF LIFE AS PRAGMATIC INDEXES OF RESPONSE [J].
TANNOCK, I ;
GOSPODAROWICZ, M ;
MEAKIN, W ;
PANZARELLA, T ;
STEWART, L ;
RIDER, W .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (05) :590-597
[48]   Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: A Canadian randomized trial with palliative end points [J].
Tannock, IF ;
Osoba, D ;
Stockler, MR ;
Ernst, DS ;
Neville, AJ ;
Moore, MJ ;
Armitage, GR ;
Wilson, JJ ;
Venner, PM ;
Coppin, CML ;
Murphy, KC .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (06) :1756-1764
[49]   MUTATION OF THE ANDROGEN-RECEPTOR GENE IN METASTATIC ANDROGEN-INDEPENDENT PROSTATE-CANCER [J].
TAPLIN, ME ;
BUBLEY, GJ ;
SHUSTER, TD ;
FRANTZ, ME ;
SPOONER, AE ;
OGATA, GK ;
KEER, HN ;
BALK, SP .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (21) :1393-1398
[50]   IMPORTANCE OF CONTINUED TESTICULAR SUPPRESSION IN HORMONE-REFRACTORY PROSTATE-CANCER [J].
TAYLOR, CD ;
ELSON, P ;
TRUMP, DL .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (11) :2167-2172
123456